Literature DB >> 12825824

Leptomeningeal dissemination of cerebellar malignant astrocytomas.

Hidenori Endo1, Toshihiro Kumabe, Hidefumi Jokura, Reizo Shirane, Hisanori Ariga, Yoshihisa Takai, Takashi Yoshimoto.   

Abstract

Primary malignant astrocytomas of the cerebellum are extremely rare, and the dissemination patterns and effectiveness of postoperative radiation therapy are unclear. Five consecutive cases of histologically proven cerebellar malignant astrocytoma, two anaplastic astrocytomas, one anaplastic pilocytic astrocytoma, and two glioblastomas, were treated between 1997 and 2001. Four patients underwent surgical removal, local irradiation, and chemotherapy, and one patient with anaplastic pilocytic astrocytoma received subtotal removal followed by gamma knife radiosurgery for the residual tumor. Two patients had no recurrence at the primary site. All patients developed leptomeningeal dissemination. Four patients had supratentorial dissemination and two patients had spinal metastases. The time interval between the diagnosis of the primary cerebellar tumor and the diagnosis of leptomeningeal dissemination was 5-29 months (mean 14.6 +/- 10.4 months). All patients died at 10-38 months (mean survival 22.2 +/- 13.6 months). Intensive treatment including chemotherapy and radiotherapy may be required in cerebellar malignant astrocytomas, considering the high incidence of symptomatic leptomeningeal dissemination.

Entities:  

Mesh:

Year:  2003        PMID: 12825824     DOI: 10.1023/a:1023983518341

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  30 in total

Review 1.  Primary cerebellar glioblastoma multiforme.

Authors:  S A Levine; P E McKeever; H S Greenberg
Journal:  J Neurooncol       Date:  1987       Impact factor: 4.130

2.  Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse.

Authors:  M Brada; K Hoang-Xuan; R Rampling; P Y Dietrich; L Y Dirix; D Macdonald; J J Heimans; B A Zonnenberg; J M Bravo-Marques; R Henriksson; R Stupp; N Yue; J Bruner; M Dugan; S Rao; S Zaknoen
Journal:  Ann Oncol       Date:  2001-02       Impact factor: 32.976

3.  Primary malignant cerebellar astrocytomas in children: a signal for postoperative craniospinal irradiation.

Authors:  O M Salazar
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-12       Impact factor: 7.038

4.  Glioblastoma multiforme in children.

Authors:  G J Dohrmann; J R Farwell; J T Flannery
Journal:  J Neurosurg       Date:  1976-04       Impact factor: 5.115

5.  Primary cerebellar glioblastomas multiforme in children. Report of four cases.

Authors:  A V Kulkarni; L E Becker; V Jay; D C Armstrong; J M Drake
Journal:  J Neurosurg       Date:  1999-03       Impact factor: 5.115

6.  Primary cerebellar glioblastoma multiforme with an unusually long survival. Case report.

Authors:  K Hegedüs; P Molnár
Journal:  J Neurosurg       Date:  1983-04       Impact factor: 5.115

7.  Leptomeningeal metastasis from supratentorial malignant gliomas.

Authors:  I Awad; J W Bay; L Rogers
Journal:  Neurosurgery       Date:  1986-08       Impact factor: 4.654

8.  Evolution and outcome in malignant astroglial neoplasms of the cerebellum.

Authors:  G K Steinberg; L M Shuer; F K Conley; J W Hanbery
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

9.  PTEN gene mutation and high MIB-1 labeling index may contribute to dissemination in patients with glioblastoma.

Authors:  Hideaki Kato; Miki Fujimura; Toshihiro Kumabe; Chikashi Ishioka; Ryunosuke Kanamaru; Takashi Yoshimoto
Journal:  J Clin Neurosci       Date:  2004-01       Impact factor: 1.961

Review 10.  Cerebellar glioblastoma multiforme; a report of two cases and review of the literature.

Authors:  T Z Aziz; M Stoddart
Journal:  West Engl Med J       Date:  1990-06
View more
  9 in total

1.  The expression status of CD133 is associated with the pattern and timing of primary glioblastoma recurrence.

Authors:  Ichiyo Shibahara; Yukihiko Sonoda; Ryuta Saito; Masayuki Kanamori; Yoji Yamashita; Toshihiro Kumabe; Mika Watanabe; Hiroyoshi Suzuki; Takashi Watanabe; Chikashi Ishioka; Teiji Tominaga
Journal:  Neuro Oncol       Date:  2013-05-07       Impact factor: 12.300

Review 2.  Cerebellar glioblastoma: a retrospective review of 21 patients at a single institution.

Authors:  Andrew J Tsung; Sujit S Prabhu; Xiudong Lei; Joshua J Chern; N Benjamin Bekele; Nicole A Shonka
Journal:  J Neurooncol       Date:  2011-06-04       Impact factor: 4.130

Review 3.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

Review 4.  Leptomeningeal metastases.

Authors:  Alexis Demopoulos
Journal:  Curr Neurol Neurosci Rep       Date:  2004-05       Impact factor: 5.081

5.  Secondary dissemination in children with high-grade malignant gliomas and diffuse intrinsic pontine gliomas.

Authors:  S Wagner; M Benesch; F Berthold; A K Gnekow; S Rutkowski; R Sträter; M Warmuth-Metz; R-D Kortmann; T Pietsch; J E A Wolff
Journal:  Br J Cancer       Date:  2006-10-03       Impact factor: 7.640

6.  De novo cerebellar malignant glioma: A case report.

Authors:  Hiroaki Matsumoto; Yasuhisa Yoshida
Journal:  Int J Surg Case Rep       Date:  2016-03-18

7.  Radiotherapy in Leptomeningeal Disease: A Systematic Review of Randomized and Non-randomized Trials.

Authors:  Samantha M Buszek; Caroline Chung
Journal:  Front Oncol       Date:  2019-11-15       Impact factor: 6.244

8.  Spinal Dissemination of Intracranial Glioblastoma in Bevacizumab Era: a Potential Bevacizumab-induced Mechanism.

Authors:  Gentian Kaloshi; Arben Roji; Arsen Seferi; Bujar Cakani; Teona Bushati; Ermir Roci; Mentor Petrela
Journal:  Acta Inform Med       Date:  2014-04

9.  Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas.

Authors:  Roland Roelz; Peter Reinacher; Ramazan Jabbarli; Rainer Kraeutle; Beate Hippchen; Karl Egger; Astrid Weyerbrock; Marcia Machein
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.